On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...
Investing.com -- Pfizer Inc. (NYSE: PFE) shares rose more than 3% on Wednesday following reports that CEO Albert Bourla is ...
With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...
While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...
We recently published a list of 10 Best Biotech Stocks To Buy Under $20. In this article, we are going to take a look at ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Two of the nation's biggest banks will kick off earnings season for lenders Friday when JPMorgan Chase and Wells Fargo report results. It was an unusual quarter for the U.S. financial system, marked ...
Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...
Before March of 2022, “the whole sector was lazy because of very cheap interest rates”, said Anuj Ranjan, the chief executive of private equity at Brookfield. Ranjan added that at that time, financial ...
Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
The CBOE Volatility index, Wall Street's fear gauge, closed up 3.4 points at 22.64, marking its biggest one-day points gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback